|View printer-friendly version|
|February 05, 2002 4:07 p.m.|
|Teva Makes Offer to Acquire French Generic Operations from Bayer|
Jerusalem, Israel, February 5, 2002 - Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) today announced that it has made a firm offer to acquire Bayer Pharma S.A.'s French generic business including marketing and manufacturing activities. The offer includes Bayer Classics S.A. a leading supplier of generic pharmaceutical products to the French retail market. Notification of Teva's offer has been made to the workers' committees of Bayer in accordance with French law. The potential acquisition in the emerging French generic market is in line with Teva's strategy to be a global generic leader and enhance its activities in Europe.